A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma


Saglam S. , Aykan N. F. , ŞAKAR B. , GÜLLÜOĞLU M. , Balik E. , Karanlik H.

JOURNAL OF GASTROINTESTINAL ONCOLOGY, vol.2, no.1, pp.19-26, 2011 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 2 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.3978/j.issn.2078-6891.2010.030
  • Title of Journal : JOURNAL OF GASTROINTESTINAL ONCOLOGY
  • Page Numbers: pp.19-26

Abstract

Background: Best response rates have been achieved with three-drug regimens containing 5-FU in the treatment of advanced gastric cancer (AGC) and oral fluoropyrimidines are the best alternatives as substitutes for infusional 5-FU. This study aimed to evaluate the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) regimens in AGC outpatients.